Vertiv Stock Soared February: What Fueled the Rally
Vertiv rode a powerful wave in February as AI-driven data-center demand accelerated and the company highlighted durab...
Choosing between a Sep Ira and a Simple Ira can be challenging. Discover the key factors to consider for your retirement savings strategy.
15,615 articlesVertiv rode a powerful wave in February as AI-driven data-center demand accelerated and the company highlighted durab...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
Global brain health costs total $5 trillion annually, with forecasts for $16 trillion by 2030. The crisis is reshapin...
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...
On Mar. 5, oil surged and AI export worries weighed on tech names, sending the S&P 500, Nasdaq, and Dow lower. This a...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
Target stock surged after the latest earnings release, sending investors back to the question: is this the start of a...
Could Nvidia stock really double by 2030? This guide weighs AI-driven growth, competitive risks, and strategies to po...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
March is delivering a notable rally as investors weigh AI momentum, earnings signals, and geopolitical headlines. Thi...
Berkshire Hathaway’s long-running bets on Coca-Cola and American Express continue to pay off in 2025. This article br...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...